In-Depth Insights into the Specimen Validity Testing Market: Growth, Trends, and Opportunities for 2025-2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the specimen validity testing market grown in recent years?
The market size of specimen validity testing has experienced robust growth in the past few years. The market, which was valued at $3.68 billion in 2024 is projected to increase to $4.03 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.7%. This growth in the historical period is due to factors such as rising drug adoption, expansion of drug screening, strict regulations, growing alcohol consumption, and the incorporation of point-of-care testing.
How is the specimen validity testing market size expected to evolve during the forecast period?
The specimen validity testing market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising demand for workplace drug testing, growing adoption of oral fluid testing, rise in research and development operations, rising usage of SVTand expanding applications in pain management. Major trends in the forecast period include technological advancements, integration of artificial intelligence for result interpretation, product innovations, increasing partnerships, and the development of portable testing devices for on-the-go monitoring.
Get your specimen validity testing market report here!
https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report
Which key drivers are propelling the specimen validity testing market’s growth?
The escalating issue of drug misuse is anticipated to fuel the expansion of the specimen validity testing market. This misuse pertains to the regular, intense, or improper consumption of legal or illegal substances not for medical uses. The growing trend of drug misuse can be attributed to a combination of various factors, including opioid addiction, emerging mental health concerns, limited availability of treatment and support facilities, and cultural representations. SVT techniques have been devised to detect the existence of contaminants and substances by evaluating several factors like pH, specific gravity, the concentration of creatinine, and temperature. For instance, as stated by the Office for Health Improvement and Disparities, a department of the UK government, in October 2023, adult engagements with drug and alcohol programs increased from April 2021 to March 2022, amounting to 0.29 million engagements, an increase from 0.28 million the preceding year. Additionally, as reported by the Office for National Statistics, a UK government organization, in October 2024, during 2023, there were 5,448 drug overdose-related deaths recorded in England and Wales, signifying an 11.0% surge from the 4,907 deaths registered in 2022. Therefore, the escalating drug misuse is anticipated to fuel the growth of the specimen validity testing market.
What are the market segments in the specimen validity testing industry?
The specimen validity testing market covered in this report is segmented –
1) By Product And Service: Products, Service
2) By Testing Type: Laboratory Testing, Rapid Or Point-Of-Care Testing
3) By End-User: Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Criminal Justice And Law Enforcement Agencies, Other End-Users
Subsegments:
1) By Products: Reagents And Assay Kits, Controls And Calibrators, Specimen Collection Devices, Analyzers And Instruments
2) By Service: Laboratory Testing Services, Point-Of-Care Testing Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15673&type=smp
What are the top market players propelling the growth of the specimen validity testing industry?
Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd
What are the key trends shaping the future of the specimen validity testing market?
Key players in the specimen validity testing market are launching innovative products such as detailed urine drug testing profiles to strengthen their market standing. Detailed urine drug testing profiles represent sophisticated testing techniques employing cutting-edge analytical processes. For example, Mayo Clinic Laboratories, a medical laboratory located in the US, rolled out a data-backed urine drug testing (UDT) profile in July 2022. This empowers doctors with critical information to handle patients addicted to substances like prescription opioids, alcohol, marijuana, and nicotine. The novel addiction medicine monitoring profile (Mayo ID ADMPU) concurs with the guidelines set by the American Society of Addiction Medicine. It ensures superior sensitivity and specificity to recognize primary drugs and metabolites of various drug classes such as opioids, benzodiazepines, stimulants, and PCP. The profile utilizes high-precision, authentic mass spectrometry for targeted and immunoassay testing for certain substances, rendering comprehensive and medically relevant data for healthcare professionals.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15673
Which geographic areas are influencing the growth of the specimen validity testing market?
North America was the largest region in the specimen validity testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Laboratory Testing Services Global Market Report 2024
Hospital Acquired Infections Testing Kits Global Market Report 2024
Rapid Microbiology Testing Kits Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
